Oncozenge AB Net Asset Momentum
Oncozenge AB net asset momentum. Oncozenge AB (ONCOZ) recorded a net asset momentum of -105.9% as of December 2025, with net assets of Skr-587.00K SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Oncozenge AB (ONCOZ) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Oncozenge AB (2020–2025)
Net asset momentum of Oncozenge AB from 2020 to 2025. This chart tracks Oncozenge AB's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is -105.9%, with net assets of Skr-587.00K SEK as of December 2025. See ONCOZ book value for net asset value and shareholders' equity analysis.
Oncozenge AB Net Asset Momentum by Year (2020–2025)
Oncozenge AB net asset momentum by year from 2020 to 2025. The table below shows the complete annual net asset history for Oncozenge AB from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Oncozenge AB stock valuation.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Skr-587.00K | Skr15.34 Million | Skr15.92 Million | ▼ -105.9% |
| 2024 | Skr9.95 Million | Skr11.43 Million | Skr1.48 Million | ▼ -46.6% |
| 2023 | Skr18.64 Million | Skr20.34 Million | Skr1.70 Million | ▼ -45.1% |
| 2022 | Skr33.97 Million | Skr36.89 Million | Skr2.92 Million | ▼ -57.7% |
| 2021 | Skr80.32 Million | Skr85.23 Million | Skr4.90 Million | ▲ +174.3% |
| 2020 | Skr29.28 Million | Skr38.30 Million | Skr9.01 Million | — |